79 related articles for article (PubMed ID: 18190883)
1. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis.
Rubinstein T; Pitashny M; Putterman C
Autoimmun Rev; 2008 Jan; 7(3):229-34. PubMed ID: 18190883
[TBL] [Abstract][Full Text] [Related]
2. Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.
Kiani AN; Wu T; Fang H; Zhou XJ; Ahn CW; Magder LS; Mohan C; Petri M
J Rheumatol; 2012 Jun; 39(6):1231-7. PubMed ID: 22505707
[TBL] [Abstract][Full Text] [Related]
3. Relationship between neutrophil gelatinase-associated lipocalin levels and disease parameters including clinicopathological parameters and various cytokine levels in systemic lupus erythematosus.
Choi EW
J Vet Med Sci; 2023 Jun; 85(6):601-608. PubMed ID: 37088550
[TBL] [Abstract][Full Text] [Related]
4. Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin.
Pawar RD; Goilav B; Xia Y; Zhuang H; Herlitz L; Reeves WH; Putterman C
Clin Immunol; 2014 Sep; 154(1):49-65. PubMed ID: 24971701
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus.
Greenan-Barrett J; Doolan G; Shah D; Virdee S; Robinson GA; Choida V; Gak N; de Gruijter N; Rosser E; Al-Obaidi M; Leandro M; Zandi MS; Pepper RJ; Salama A; Jury EC; Ciurtin C
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299237
[TBL] [Abstract][Full Text] [Related]
6. Stability of novel urinary biomarkers used for lupus nephritis.
Cody EM; Rose JE; Huang B; Qiu T; Brunner HI; Devarajan P
Front Pediatr; 2022; 10():974049. PubMed ID: 35967565
[TBL] [Abstract][Full Text] [Related]
7. Serum exosomal tsRNA biomarkers: A novel strategy for identifying lupus nephritis.
Yang P; Sun Y; Wang C; Li Z; Han Y; Gong J; Khan A; Wang J; Wang Y; Jin F; Li Z
Clin Transl Med; 2024 May; 14(5):e1677. PubMed ID: 38760892
[No Abstract] [Full Text] [Related]
8. Retraction: Urinary Neutrophil Gelatinase-Associated Lipocalin and Urinary Soluble CXCL16 as Biomarkers of Activity in Pediatric Lupus Nephritis.
Indian J Nephrol; 2023; 33(6):492. PubMed ID: 38174293
[TBL] [Abstract][Full Text] [Related]
9. Role of Plasma Neutrophil Gelatinase Associated Lipocalin as a New Biomarker.
Hlinomaz O
J Crit Care Med (Targu Mures); 2016 Jan; 2(1):56-57. PubMed ID: 29967838
[No Abstract] [Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.
Suzuki M; Wiers KM; Klein-Gitelman MS; Haines KA; Olson J; Onel KB; O'Neil K; Passo MH; Singer NG; Tucker L; Ying J; Devarajan P; Brunner HI
Pediatr Nephrol; 2008 Mar; 23(3):403-12. PubMed ID: 18202859
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.
Bolignano D; Donato V; Coppolino G; Campo S; Buemi A; Lacquaniti A; Buemi M
Am J Kidney Dis; 2008 Sep; 52(3):595-605. PubMed ID: 18725016
[TBL] [Abstract][Full Text] [Related]
12. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children.
Hammad A; Mosaad Y; Elhanbly S; Youssef H; El Refaaey A; Elhusseini F; Bakr A
Lupus; 2013 Apr; 22(5):486-91. PubMed ID: 23554037
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis.
Torres-Salido MT; Cortés-Hernández J; Vidal X; Pedrosa A; Vilardell-Tarrés M; Ordi-Ros J
Nephrol Dial Transplant; 2014 Sep; 29(9):1740-9. PubMed ID: 24711435
[TBL] [Abstract][Full Text] [Related]
14. High-throughput CRISPR technology: a novel horizon for solid organ transplantation.
Li X; Chen Z; Ye W; Yu J; Zhang X; Li Y; Niu Y; Ran S; Wang S; Luo Z; Zhao J; Hao Y; Zong J; Xia C; Xia J; Wu J
Front Immunol; 2023; 14():1295523. PubMed ID: 38239344
[TBL] [Abstract][Full Text] [Related]
15. The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL).
Romejko K; Markowska M; Niemczyk S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445650
[TBL] [Abstract][Full Text] [Related]
16. Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis.
Tsai CY; Li KJ; Shen CY; Lu CH; Lee HT; Wu TH; Ng YY; Tsao YP; Hsieh SC; Yu CL
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373215
[TBL] [Abstract][Full Text] [Related]
17. Comparison urine neutrophil gelatinase - associated lipocalin with standard parameters in monitoring activity Lupus nephritis: Class IV.
Rabrenović V; Petrović M; Rabrenović M
J Med Biochem; 2023 Jan; 42(1):78-85. PubMed ID: 36819131
[TBL] [Abstract][Full Text] [Related]
18. Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation.
Dufrusine B; Valentinuzzi S; Bibbò S; Damiani V; Lanuti P; Pieragostino D; Del Boccio P; D'Alessandro E; Rabottini A; Berghella A; Allocati N; Falasca K; Ucciferri C; Mucedola F; Di Perna M; Martino L; Vecchiet J; De Laurenzi V; Dainese E
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613462
[TBL] [Abstract][Full Text] [Related]
19. Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature.
Palazzo L; Lindblom J; Mohan C; Parodis I
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233628
[TBL] [Abstract][Full Text] [Related]
20. A neutrophil activation signature predicts critical illness and mortality in COVID-19.
Meizlish ML; Pine AB; Bishai JD; Goshua G; Nadelmann ER; Simonov M; Chang CH; Zhang H; Shallow M; Bahel P; Owusu K; Yamamoto Y; Arora T; Atri DS; Patel A; Gbyli R; Kwan J; Won CH; Dela Cruz C; Price C; Koff J; King BA; Rinder HM; Wilson FP; Hwa J; Halene S; Damsky W; van Dijk D; Lee AI; Chun HJ
Blood Adv; 2021 Mar; 5(5):1164-1177. PubMed ID: 33635335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
